(Press-News.org) Platelets are small, disc-shaped cell fragments in the blood that are essential to stop bleeding and to initiate blood clotting after injury. Platelet transfusions in patients with severe trauma or medical conditions, including bone marrow disease, leukemia, or sepsis, can be lifesaving. Despite being a standard clinical practice, platelet transfusions face issues related to the availability of blood donations from which platelets are isolated, the relatively short shelf life of purified platelets, and the risk of an immune response in patients receiving platelets from unmatched donors.
A potential solution to this has been proposed by the team of Koji Eto at the Center for iPS Cell Research and Application at Kyoto University, Japan, who invented a method for manufacturing platelet-producing cells, megakaryocytes, from stem cells. Via genetic engineering, Koji’s team first made so-called induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells and then converted them into megakaryocytes in the lab. Platelets can then be harvested from the megakaryocyte cultures and given back to the same patient, thereby avoiding immune rejection.
Although this strategy, in theory, provides an unlimited supply of patient-derived platelets, some impediments towards industrial large-scale production remain, most notably variable efficiency of platelet production from megakaryocytes across different patients and a decrease in productivity over time. In their work published today in Stem Cell Reports, Eto’s team addresses these issues by showing that megakaryocyte growth is directly linked to platelet production and is controlled by the protein KAT7, which acts as a “molecular switch.” While megakaryocytes with high KAT7 levels divide fast and make high amounts of platelets, megakaryocytes with low KAT7 levels switch behavior—they stop multiplying, accumulate DNA damage, and produce more inflammatory proteins—while at the same time ceasing platelet production. This work demonstrates that maintaining high cellular KAT7 levels is essential for consistently high platelet production from stem cell-derived megakaryocytes. Monitoring KAT7 levels can potentially be used for quality control during clinical-scale production and thus be leveraged to ensure efficient and consistent platelet manufacturing across patients.
About Stem Cell Reports
Stem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. Stem Cell Reports is a Cell Press partner journal. Find the journal on X: @StemCellReports.
About ISSCR
With nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.
END
Scientists use stem cells to move closer to large-scale manufacturing of platelets
2025-11-13
ELSE PRESS RELEASES FROM THIS DATE:
High-engagement social media posts related to prescription drug promotion for 3 major drug classes
2025-11-13
About The Study: The current analysis illustrates that drug promotion content is frequently posted by individual creators, lacks essential risk information, and bears the hallmarks of undisclosed marketing. These findings suggest that posts circumvented established advertising principles and potentially eroded the fair balance crucial for informed patient decision-making, consistent with prior literature on traditional direct-to-consumer advertising’s impact on prescribing.
Corresponding Author: To contact the corresponding author, Alex Kresovich, PhD, email kresovich-alex@norc.org.
To access the embargoed ...
Ultraprocessed food consumption and risk of early-onset colorectal cancer precursors among women
2025-11-13
About The Study: In this study, higher ultraprocessed food intake was associated with increased risk of early-onset colorectal conventional adenomas. These data highlight the important role of ultraprocessed foods in early-onset colorectal tumorigenesis and support improving dietary quality as a strategy to mitigate the increasing burden of early-onset colorectal cancer.
Corresponding Author: To contact the corresponding author, Andrew T. Chan, MD, MPH, email achan@mgh.harvard.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2025.4777)
Editor’s Note: Please see the ...
New study could help your doctor make smarter treatment decisions
2025-11-13
Thoughtful electronic health record system design can nudge physicians toward evidence-based, less invasive treatments
Doctors offered two or more treatment alternatives were significantly more likely to choose a better option (62%) than those offered only one (44%)
‘We’re trying to make it easier for physicians to do the right thing’
CHICAGO --- Having more options is always better — until it’s not.
Doctors face this paradox daily when choosing treatment plans for patients, especially under the pressure of packed clinical schedules. Too few choices can limit care, but too many can lead to decision ...
Study finds adults who consumed more ultra-processed foods had higher rates of precursors of early-onset colorectal cancer
2025-11-13
Colorectal cancer used to be associated with old age, but diagnoses have become increasingly common in adults aged 50 or younger particularly in high-income countries like the United States. The reason for this trend is unclear, but a new study led by Mass General Brigham researchers, as part of the Cancer Grand Challenges PROSPECT team, suggests an important link to ultra-processed foods that merits closer investigation. By analyzing the diets and endoscopy results from almost 30,000 women, the team ...
Pancreatic cancer research project attacks ‘seeds of metastasis’
2025-11-13
Pinned between the stomach and spine, the pancreas supervises both digestion and blood sugar in the body. It’s also the site of an aggressive cancer called pancreatic ductal adenocarcinoma, or PDAC.
PDAC is the most common type of pancreatic cancer, the third-leading cause of cancer deaths in the U.S. It’s difficult to detect and recurs about 70% of the time after treatment. Only 13% of those diagnosed survive more than five years.
A team of surgeons, anesthesiologists and engineers at the University of ...
How can AI sentiment analysis apply to complex medical diagnoses?
2025-11-13
Taking a page from market research tactics, UC San Francisco experts are studying whether artificial intelligence (AI) can improve diagnosis of a complex liver condition by using the clinical notes of multiple providers.
Their recent study, published in Gastro Hep Advances, focused on hepatorenal syndrome (HRS), a complex condition associated with liver disease that is often difficult to diagnose during hospitalization. The researchers sought to learn if large language models could analyze the clinical notes of multiple physicians and other providers to improve ...
1st death linked to ‘meat allergy’ spread by ticks
2025-11-13
University of Virginia School of Medicine researchers have identified the first death caused by what is commonly called the “meat allergy” being spread by ticks.
A healthy 47-year-old man from New Jersey died abruptly four hours after consuming beef. The cause of his death had been a mystery until UVA Health’s Thomas Platts-Mills, MD, PhD, investigated. A world-renowned allergist, Platts-Mills discovered the allergy and remains the foremost expert on it.
The allergy is caused by the bite of the Lone Star tick. Bites can sensitize people to alpha-gal, a sugar found in mammalian meat. People who become sensitized to the sugar can have allergic symptoms such as rash, nausea ...
The role of hepatic SIRT1: From metabolic regulation to immune modulation and multi-target therapeutic strategies
2025-11-13
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disorder globally, with a rising incidence linked to metabolic syndrome. Its pathogenesis involves a complex interplay of lipid metabolic dysregulation, insulin resistance, oxidative stress, chronic inflammation, and gut-liver axis disruption. Despite recent advances such as Resmethron for advanced metabolic-associated steatohepatitis (MASH), early-stage interventions remain limited. This ...
Lymphoma and targeted therapy: resistance mechanisms and future solutions
2025-11-13
“This review synthesizes current evidence to inform clinical decision-making and outlines future directions for durable, personalized lymphoma care.”
BUFFALO, NY — November 13, 2025 — A new review was published in Volume 12 of Oncoscience on October 13, 2025, titled “Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions.”
In this article by Bishal Tiwari, Roshan Afshan and Shruthi Sridhar, from Nassau University Medical Center and Detroit Medical Center Wayne State University, researchers reviewed the latest scientific ...
2025 AAAS Kavli Science Journalism Award Winners Named
2025-11-13
Stories describing what can happen when science is manipulated or misapplied are among the winners of the 2025 AAAS Kavli Science Journalism Awards. Winning journalists also did stories on science at its best, revealing new understanding about the natural world.
Independent panels of science journalists select the winners of the awards, which are administered by the American Association for the Advancement of Science (AAAS) and endowed by The Kavli Foundation. There is a Gold Award ($5,000) and Silver Award ($3,500) for each of the eight categories. The global awards program drew entries from 67 countries this year, and 55 percent of the ...